Singapore markets closed
Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,865.79 -11.26 (-0.14%) Bitcoin USD
64,634.17 +898.92 (+1.41%) CMC Crypto 200
1,381.23 +68.61 (+5.52%)
Moringa Acquisition Corp (MACAU)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
As of 04:00PM EDT. Market open.
| Previous close | 10.71 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 10.97 - 10.97 |
| 52-week range | 9.63 - 10.97 |
| Volume | |
| Avg. volume | 9 |
| Market cap | N/A |
| Beta (5Y monthly) | 0.01 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.06 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireSilexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
Silexion’s first generation product, Loder™, successfully tested in a multinational Phase 2a clinical trial in patients with non-resectable pancreatic cancer which harbors an oncogene believed to be a major driver of the cancer In combination with chemotherapy, Loder resulted in a median overall survival (OS) advantage of 9.3 months over chemotherapy alone (22.7 vs 13.4 months) Modi’in, Israel and New York, New York, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (Nasdaq: MACA) (“Mor
© 2024 Yahoo. All rights reserved.